Advances in Laser Scanning Imaging Cytometry for High-Content Screening
Interview with Mel Reichman, PhD
Assessing Drug Efficacy in a Miniaturized Pancreatic Cancer In Vitro 3D Cell Culture Model
Drug Repurposing Patent Applications January–March 2016
Pharmacological Modulation of GluK1 and GluK2 by NETO1, NETO2, and PSD95
Interview with Raúl Insa, MD, PhD
Linking Phenotypes and Modes of Action Through High-Content Screen Fingerprints
High-Content Assays for Characterizing the Viability and Morphology of 3D Cancer Spheroid Cultures
Epigenetic Drug Discovery: Great Potential and Significant Challenges
Adapting High-Throughput Screening Methods and Assays for Biocontainment Laboratories
A Macrophage Infection Model to Predict Drug Efficacy Against Mycobacterium Tuberculosis
Interview with Thomas Lundbäck, PhD
Discriminating High-Value Hits from PAINS
Diaphorase Coupling Protocols for Red-Shifting Dehydrogenase Assays